A Single Centre Study to Describe the Changes in Serum Testosterone Concentration Following Application of Testosterone Gel in Post‐Menopausal Women With Hypoactive Sexual Desire Disorder (HSSD) Already Receiving This as Part of Usual Care in Conjunc
We found considerable variation in all parameters relating to testosterone pharmacokinetics in women applying 20.25 mg testosterone gel in a 3 or 4-day regime. All women described clinical benefit prior to the study, with no reports of androgen-related side-effects. Progression to a daily licensed topical formulation of testosterone, where this is not available, would be a positive step for women's health.
Authors
- Mark Livingston (ORCID: https://orcid.org/0000-0001-6878-0769)
- Joanna Borzomato
- Peter Nicholas Taylor (ORCID: https://orcid.org/0000-0002-3436-422X)
- Rupinder Kochhar (ORCID: https://orcid.org/0000-0003-2533-2549)
- Y. A. Illangasekera (ORCID: https://orcid.org/0000-0002-7466-5502)
- Adrian Hugh Heald (ORCID: https://orcid.org/0000-0002-9537-4050)
- Mathilde Mordaunt
- Hassan Rehman
- Anne Keen
- Geoff Hackett
- Nicholas Panay
Institutions
- University of Peradeniya (LK)
- University of Wolverhampton (GB)
- Aston University (GB)
- University of Manchester (GB)
- Salford Royal Hospital (GB)
- Queen Charlotte's and Chelsea Hospital (GB)
- The Royal Wolverhampton NHS Trust (GB)
- University of Wales Institute Cardiff (SG)
- Sheffield Hallam University (GB)
Publication Details
- Journal
- Clinical Endocrinology
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1111/cen.70119
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00